Nav1.8 subunit sodium channel antagonists (Anabios)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNav1.8 subunit sodium channel antagonists (Anabios)
Drug Alias NameNav1.8 subunit sodium channel antagonists (Zalicus)voltage-gated sodium channel 1.8 antagonists (Zalicus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZalicus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnabios CorpZalicus Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A